CBD Reduced Bone Loss from Gum Disease in Rats
Daily CBD treatment reduced alveolar bone loss in rats with experimentally induced periodontal disease by suppressing RANKL/RANK expression and pro-inflammatory cytokines.
Quick Facts
What This Study Found
Researchers induced periodontal disease in rats using ligatures around the lower first molars and treated them with CBD (5 mg/kg daily) or vehicle for 30 days.
CBD-treated animals showed significantly less alveolar bone loss compared to untreated animals with periodontal disease.
The protective effect was associated with lower expression of RANKL/RANK, molecules that drive bone resorption. CBD-treated gingival tissue also showed decreased neutrophil migration and reduced levels of the pro-inflammatory cytokines IL-1beta and TNF-alpha.
Key Numbers
CBD dose: 5 mg/kg daily for 30 days. CBD reduced alveolar bone loss, RANKL/RANK expression, neutrophil migration (MPO), IL-1beta, and TNF-alpha in gingival tissues.
How They Did This
Rat periodontal disease model using ligature placement around mandibular first molars. Three groups: healthy control, ligature + vehicle, ligature + CBD (5 mg/kg daily). After 30 days, bone loss was measured morphometrically, RANKL/RANK expression was assessed, and neutrophil migration (MPO) and cytokine levels (IL-1beta, TNF-alpha) were measured in gingival tissue.
Why This Research Matters
Periodontal disease affects a large proportion of the global population and leads to tooth loss through inflammatory bone destruction. An anti-inflammatory compound that also reduces bone resorption could address both aspects of the disease process.
The Bigger Picture
This study expanded CBD research into dental medicine. The dual action of reducing both inflammation and bone resorption through the RANKL/RANK pathway suggests CBD could be relevant to other conditions involving inflammatory bone loss, such as osteoporosis and rheumatoid arthritis.
What This Study Doesn't Tell Us
Animal model of periodontal disease using ligatures is an artificial induction method. CBD was administered systemically rather than locally to the gums. Rat periodontal anatomy and healing differ from humans.
Questions This Raises
- ?Would locally applied CBD (in toothpaste or mouthwash) produce similar effects?
- ?Could CBD benefit human periodontal patients?
- ?Does CBD affect bone metabolism in other skeletal sites?
Trust & Context
- Key Stat:
- CBD reduced bone loss and inflammatory markers in rat gum disease model
- Evidence Grade:
- Animal study with a single CBD dose in an artificial periodontal disease model. Promising mechanism but far from clinical application.
- Study Age:
- Published in 2009. CBD and bone health research has continued to expand, though clinical evidence in dental settings remains limited.
- Original Title:
- Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats.
- Published In:
- International immunopharmacology, 9(2), 216-22 (2009)
- Authors:
- Napimoga, Marcelo H, Benatti, Bruno B, Lima, Flavia O, Alves, Polyanna M, Campos, Alline C, Pena-Dos-Santos, Diego R, Severino, Fernando P, Cunha, Fernando Q, Guimarães, Francisco S
- Database ID:
- RTHC-00377
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Could CBD help with gum disease in humans?
This animal study showed promising results, but human clinical trials would be needed to determine whether CBD could benefit periodontal patients. The anti-inflammatory and bone-protective effects are plausible mechanisms but unproven in humans.
What is RANKL and why does it matter?
RANKL is a molecule that activates osteoclasts (bone-destroying cells). In periodontal disease, excessive RANKL leads to bone loss around teeth. By reducing RANKL expression, CBD may slow the bone destruction that leads to tooth loss.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-00377APA
Napimoga, Marcelo H; Benatti, Bruno B; Lima, Flavia O; Alves, Polyanna M; Campos, Alline C; Pena-Dos-Santos, Diego R; Severino, Fernando P; Cunha, Fernando Q; Guimarães, Francisco S. (2009). Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats.. International immunopharmacology, 9(2), 216-22. https://doi.org/10.1016/j.intimp.2008.11.010
MLA
Napimoga, Marcelo H, et al. "Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats.." International immunopharmacology, 2009. https://doi.org/10.1016/j.intimp.2008.11.010
RethinkTHC
RethinkTHC Research Database. "Cannabidiol decreases bone resorption by inhibiting RANK/RAN..." RTHC-00377. Retrieved from https://rethinkthc.com/research/napimoga-2009-cannabidiol-decreases-bone-resorption
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.